论文部分内容阅读
对32例食管癌病人和119例健康人的检测结果表明:病人与健康人的Cu·Zn-SOD值之间未见显著差异(P>0.01),但南澳病人血Cu·Zn-SOD值明显低于汕头住院病人(P<0.01).健康人不同年龄组Cu·Zn-SOD值有显著差异(P<0.05),且高龄组17人(平均51岁)普遍都高,其中64％高于400μg/g-Hb,而低龄组73人(平均21岁)中,仅有31％高于此值. 唾液蛋白凝胶电泳相SPO同功酶的分析初步见到一些差异现象.
The results of 32 cases of esophageal cancer patients and 119 healthy persons showed that there was no significant difference between the Cu and Zn-SOD values of patients and healthy individuals (P>0.01), but the blood Cu·Zn-SOD values of patients in South Australia were significant. The hospitalized patients were lower than those in Shantou (P<0.01). There was a significant difference in Cu.Zn-SOD values among different age groups in healthy people (P<0.05), and 17 in the senior age group (average 51 years old) were generally high, with 64% being higher than 400μg/g-Hb, compared with 73% (average 21 years old) in the younger age group, only 31% was higher than this value. The analysis of SPO isoenzymes in the electrophoresis of salivary protein gels initially showed some differences.